Slides - Clinical Trial Results .org

More documents

Recommendations

Info

<strong>Results</strong>: Presenting Characteristics (N=871) GIK (n=411) Placebo (n=460) Age (mean, yrs) 64 63 Men 73% 70% White/Black/Hispanic (%) 82/13/11% 87/9/13% Chest pain chief complaint 87% 85% Shortness of breath chief complaint 4% 4% Pre-hospital systolic BP (mean, mmHg) 143 143 Pre-hospital HR (mean, BPM) 87 87 History of DM 29% 26% History of HF 17% 17% History of MI 37% 35%
<strong>Results</strong>: Time from Ischemic Symptom Onset to EMS Start of Study Drug Infusion GIK (n=411) Placebo (n=460) Time from symptom onset to study drug (median, mins [IQR]) 90 [50-159] 90 [52-159] Time from symptom onset to study drug 0-30 mins 6% 4% 31-60 mins 25% 27% 61-90 mins 15% 16% 91-180 mins 17% 18% 181-360 mins 12% 12% 361 mins-24 hrs 9% 8% Patients received primary PCI 48% 45%
Page 1 and 2: Results of the IMMEDIATE (Immediate
Page 3 and 4: Carl Apstein, MD, FACC The IMMEDIAT
Page 5 and 6: Background: Rationale for Placebo-C
Page 7 and 8: Methods: Basic Features of Study De
Page 9 and 10: Methods: Pre-Specified Endpoints
Page 11 and 12: Methods: Exclusion Criteria • HF
Page 13 and 14: Methods: Analysis • Sample size c
Page 15: Results: Screening and Enrollment o
Page 19 and 20: Results: ITT Cohort Hospital and 30
Page 21 and 22: Results: ITT Cohort Hospital and 30
Page 23 and 24: Results: Cohort Presenting with ST
Page 25 and 26: Results: Cohort Presenting with ST
Page 27 and 28: Median infarct size (IQR) Results:
Page 29 and 30: Median infarct size (IQR) Results:
Page 31 and 32: Limitations • Primary endpoint pr
Page 33 and 34: James Atkins • Assaad Sayah • M

Slides - Clinical Trial Results .org

Create successful ePaper yourself

Delete template?

Save as template?